5ebb67c9fd07395c97e41e2ddb60c30c 302153.pdf 23ab71403de5863dbc33844eaeb24f009055418c 302153.pdf 8c4960daa8a86f4257edc61c097d8a95182edd949b1b82dcf3fd819b72fb7fcb 302153.pdf Title: Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study Subject: DOI: 10.1093/ofid/ofad626; Open Forum Infectious Diseases, 11, 1, 2023-12-09.; Abstract: Background: We compared proportions of participants with target detected, target not detected (TND), and elevated viral load (VL) and assessed baseline variables associated with week 144 inflammatory biomarker levels between dolutegravir-lamivudine (DTG/3TC) and tenofovir alafenamide–based regimens (TBRs) in the TANGO study (post hoc). Methods: TANGO is an open-label, multicenter, phase 3 study that randomized adults with VL <50 copies/mL to switch to once-daily fixed-dose DTG/3TC or continue TBR. At baseline and each study visit, the VL was measured. Elevated VL event frequencies were assessed, including “blips.” Interleukin 6, D-dimer, high-sensitivity C-reactive protein, soluble CD14, and soluble CD163 were measured at baseline and at week 144. Loge-transformed week 144 biomarker levels were compared between treatment groups using an analysis of covariance model adjusting for baseline variables. Result Keywords: 2-drug regimen; dolutegravir-lamivudine; inflammation; integrase strand transfer inhibitor; virologic suppression Author: Ruolan Wang Creator: Servigistics Arbortext Advanced Print Publisher 11.1.4546/W-x64 Producer: PDFlib+PDI 9.0.7p3 (C++/Win64); modified using iTextSharp 4.1.6 by 1T3XT CreationDate: Wed Jan 10 18:45:18 2024 CET ModDate: Wed Dec 18 11:16:25 2024 CET Custom Metadata: yes Metadata Stream: yes Tagged: yes UserProperties: no Suspects: no Form: none JavaScript: no Pages: 10 Encrypted: no Page size: 593.972 x 782.986 pts Page rot: 0 File size: 551855 bytes Optimized: no PDF version: 1.6 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- CCDFKE+UniversLTStd-Cn Type 1C Custom yes yes yes 759 0 CTDXPN+UniversLTStd-LightCnObl Type 1C Custom yes yes yes 47 0 ESWMTR+MinionPro-Bold Type 1C Custom yes yes yes 30 0 JXXSFM+STIXGeneral-Regular Type 1C Custom yes yes yes 31 0 AIPMBV+MinionPro-BoldIt Type 1C Custom yes yes yes 82 0 NOXVRE+UniversLTStd-LightCn Type 1C Custom yes yes yes 48 0 EXSRKC+UniversLTStd-BoldCn Type 1C Custom yes yes yes 32 0 WLLXYU+MinionPro-Regular Type 1C Custom yes yes yes 33 0 YSUJCO+ArialMT TrueType WinAnsi yes yes no 1 0 AMZXBD+UniversLTStd-Black Type 1C Custom yes yes yes 29 0 WEEPPA+UniversLTStd-Light Type 1C Custom yes yes yes 37 0 DNWJYN+MinionPro-It Type 1C Custom yes yes yes 41 0 NFFJQO+TimesNewRomanPSMT CID TrueType Identity-H yes yes yes 42 0 Helvetica-Bold Type 1 Custom no no no 52 0 NSLBUP+Arial-BoldMT Type 1 Custom yes yes no 53 0 GSSTKI+ArialMT Type 1 Custom yes yes no 54 0 QEHLYA+ArialMT Type 1 Custom yes yes no 62 0 BDJZOV+Arial-BoldMT Type 1 Custom yes yes no 63 0 Helvetica-Bold Type 1 Custom no no no 72 0 MBGKSU+Arial-BoldMT Type 1 Custom yes yes no 73 0 QIVXWJ+Arial-BoldMT Type 1 Custom yes yes no 74 0 GSSTKI+ArialMT Type 1 Custom yes yes no 75 0 Jhove (Rel. 1.28.0, 2023-05-18) Date: 2024-12-20 02:48:14 CET RepresentationInformation: 302153.pdf ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16) LastModified: 2024-12-19 09:42:25 CET Size: 551855 Format: PDF Version: 1.6 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf Profile: Tagged PDF PDFMetadata: Objects: 818 FreeObjects: 1 IncrementalUpdates: 0 DocumentCatalog: ViewerPreferences: HideToolbar: false HideMenubar: false HideWindowUI: false FitWindow: false CenterWindow: false DisplayDocTitle: true NonFullScreenPageMode: UseNone Direction: L2R ViewArea: CropBox ViewClip: CropBox PrintArea: CropBox PageClip: CropBox PageLayout: OneColumn PageMode: UseOutlines Language: en Outlines: Item: Title: Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study Destination: head1 Children: Item: Title: METHODS Destination: secofad626-s0 Children: Item: Title: Participants and Study Design Destination: secofad626-s0.1 Item: Title: Procedures Destination: secofad626-s0.2 Item: Title: Ethical Approval Destination: secofad626-s0.3 Item: Title: Patient Consent Statement Destination: secofad626-s0.4 Item: Title: Statistical Analysis Destination: secofad626-s0.5 Item: Title: RESULTS Destination: secofad626-s1 Children: Item: Title: Study Participants Destination: secofad626-s1.1 Item: Title: VL Assessments Destination: secofad626-s1.2 Item: Title: Inflammatory Biomarkers Destination: secofad626-s1.3 Item: Title: DISCUSSION Destination: secofad626-s2 Item: Title: Supplementary Data Destination: secofad626-s3 Item: Title: Acknowledgments Destination: acknow Item: Title: References Destination: reflist Info: Title: Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study Author: Ruolan Wang Subject: DOI: 10.1093/ofid/ofad626; Open Forum Infectious Diseases, 11, 1, 2023-12-09.; Abstract: Background: We compared proportions of participants with target detected, target not detected (TND), and elevated viral load (VL) and assessed baseline variables associated with week 144 inflammatory biomarker levels between dolutegravir-lamivudine (DTG/3TC) and tenofovir alafenamide–based regimens (TBRs) in the TANGO study (post hoc). Methods: TANGO is an open-label, multicenter, phase 3 study that randomized adults with VL <50 copies/mL to switch to once-daily fixed-dose DTG/3TC or continue TBR. At baseline and each study visit, the VL was measured. Elevated VL event frequencies were assessed, including “blips.” Interleukin 6, D-dimer, high-sensitivity C-reactive protein, soluble CD14, and soluble CD163 were measured at baseline and at week 144. Loge-transformed week 144 biomarker levels were compared between treatment groups using an analysis of covariance model adjusting for baseline variables. Result Keywords: 2-drug regimen; dolutegravir-lamivudine; inflammation; integrase strand transfer inhibitor; virologic suppression Creator: Servigistics Arbortext Advanced Print Publisher 11.1.4546/W-x64 Producer: PDFlib+PDI 9.0.7p3 (C++/Win64); modified using iTextSharp 4.1.6 by 1T3XT CreationDate: Wed Jan 10 19:15:18 CET 2024 ModDate: Wed Dec 18 11:16:25 CET 2024 ID: 0x91b894505de79d6d4459feff1a3f9594, 0x5a3028c652751036856d48bec05c785b Filters: FilterPipeline: FlateDecode Fonts: Type0: Font: BaseFont: NFFJQO+TimesNewRomanPSMT Encoding: Identity-H ToUnicode: true Type1: Font: BaseFont: NOXVRE+UniversLTStd-LightCn FontSubset: true FirstChar: 1 LastChar: 75 FontDescriptor: FontName: NOXVRE+UniversLTStd-LightCn Flags: Nonsymbolic FontBBox: -163, -250, 1000, 953 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: EXSRKC+UniversLTStd-BoldCn FontSubset: true FirstChar: 1 LastChar: 62 FontDescriptor: FontName: EXSRKC+UniversLTStd-BoldCn Flags: Nonsymbolic, ForceBold FontBBox: -83, -250, 1000, 969 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: WLLXYU+MinionPro-Regular FontSubset: true FirstChar: 1 LastChar: 89 FontDescriptor: FontName: WLLXYU+MinionPro-Regular Flags: Nonsymbolic FontBBox: -290, -360, 1684, 989 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: AIPMBV+MinionPro-BoldIt FontSubset: true FirstChar: 1 LastChar: 30 FontDescriptor: FontName: AIPMBV+MinionPro-BoldIt Flags: Nonsymbolic, Italic, ForceBold FontBBox: -230, -360, 1684, 1032 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: WEEPPA+UniversLTStd-Light FontSubset: true FirstChar: 1 LastChar: 61 FontDescriptor: FontName: WEEPPA+UniversLTStd-Light Flags: Nonsymbolic FontBBox: -151, -250, 1000, 957 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: CCDFKE+UniversLTStd-Cn FontSubset: true FirstChar: 1 LastChar: 10 FontDescriptor: FontName: CCDFKE+UniversLTStd-Cn Flags: Nonsymbolic FontBBox: -166, -250, 1000, 989 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: DNWJYN+MinionPro-It FontSubset: true FirstChar: 1 LastChar: 21 FontDescriptor: FontName: DNWJYN+MinionPro-It Flags: Nonsymbolic, Italic FontBBox: -201, -360, 1684, 1002 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: AMZXBD+UniversLTStd-Black FontSubset: true FirstChar: 1 LastChar: 33 FontDescriptor: FontName: AMZXBD+UniversLTStd-Black Flags: Nonsymbolic, ForceBold FontBBox: -153, -250, 992, 986 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: ESWMTR+MinionPro-Bold FontSubset: true FirstChar: 1 LastChar: 22 FontDescriptor: FontName: ESWMTR+MinionPro-Bold Flags: Nonsymbolic, ForceBold FontBBox: -318, -360, 1684, 1024 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: CTDXPN+UniversLTStd-LightCnObl FontSubset: true FirstChar: 1 LastChar: 20 FontDescriptor: FontName: CTDXPN+UniversLTStd-LightCnObl Flags: Nonsymbolic, Italic FontBBox: -169, -271, 1065, 953 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: JXXSFM+STIXGeneral-Regular FontSubset: true FirstChar: 1 LastChar: 7 FontDescriptor: FontName: JXXSFM+STIXGeneral-Regular Flags: Nonsymbolic FontBBox: -995, -455, 2000, 1055 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true TrueType: Font: BaseFont: YSUJCO+ArialMT FontSubset: true FirstChar: 32 LastChar: 121 FontDescriptor: FontName: YSUJCO+ArialMT Flags: Nonsymbolic FontBBox: -664, -324, 2000, 1039 FontFile2: true Encoding: WinAnsiEncoding CIDFontType2: Font: BaseFont: NFFJQO+TimesNewRomanPSMT CIDSystemInfo: Registry: Adobe Registry: Identity Supplement: 0 FontDescriptor: FontName: NFFJQO+TimesNewRomanPSMT Flags: Nonsymbolic FontBBox: -568, -307, 2046, 1040 FontFile2: true XMP: uuid:36081fae-6381-4cdc-a564-a2765f94e5fc uuid:AA9FD8C2-2697-BE36-E17E-0693C000FEAF True 2-drug regimen; dolutegravir-lamivudine; inflammation; integrase strand transfer inhibitor; virologic suppression PDFlib+PDI 9.0.7p3 (C++/Win64); modified using iTextSharp 4.1.6 by 1T3XT application/pdf 10.1093/ofid/ofad626 en Oxford University Press Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study Ruolan Wang Mark Underwood Josep M. Llibre Enrique Bernal Morell Cynthia Brinson José Sanz Moreno Stefan Scholten Richard Moore Parminder Saggu James Oyee Riya Moodley Brian Wynne Michelle Kisare Bryn Jones Mounir Ait-Khaled DOI: 10.1093/ofid/ofad626; Open Forum Infectious Diseases, 11, 1, 2023-12-09.; Abstract: Background: We compared proportions of participants with target detected, target not detected (TND), and elevated viral load (VL) and assessed baseline variables associated with week 144 inflammatory biomarker levels between dolutegravir-lamivudine (DTG/3TC) and tenofovir alafenamide–based regimens (TBRs) in the TANGO study (post hoc). Methods: TANGO is an open-label, multicenter, phase 3 study that randomized adults with VL <50 copies/mL to switch to once-daily fixed-dose DTG/3TC or continue TBR. At baseline and each study visit, the VL was measured. Elevated VL event frequencies were assessed, including “blips.” Interleukin 6, D-dimer, high-sensitivity C-reactive protein, soluble CD14, and soluble CD163 were measured at baseline and at week 144. Loge-transformed week 144 biomarker levels were compared between treatment groups using an analysis of covariance model adjusting for baseline variables. Result © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2-drug regimen dolutegravir-lamivudine inflammation integrase strand transfer inhibitor virologic suppression Journal Open Forum Infectious Diseases © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2328-8957 11 1 1 10 10.1093/ofid/ofad626 https://doi.org/10.1093/ofid/ofad626 2024-01-10T23:15:18+05:30 2024-12-18T10:16:25+00:00 Servigistics Arbortext Advanced Print Publisher 11.1.4546/W-x64 2024-12-18T10:16:25+00:00 PStill version 1.84.42 1 PDF/UA Universal Accessibility Schema http://www.aiim.org/pdfua/ns/id/ pdfuaid part Integer internal Indicates, which part of ISO 14289 standard is followed Pages: Page: Sequence: 1 Annotations: Annotation: Subtype: Link Rect: 94, 615, 97, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 98, 617, 102, 624 Flags: Print Annotation: Subtype: Link Rect: 164, 615, 167, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 221, 615, 224, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 301, 615, 304, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 360, 615, 363, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 427, 615, 430, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 486, 615, 489, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 541, 615, 544, 623 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 107, 605, 110, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 154, 605, 157, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 206, 605, 209, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 255, 605, 258, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 315, 605, 318, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 359, 605, 362, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 439, 605, 442, 613 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 133, 266, 137, 275 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 277, 240, 282, 249 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 455, 292, 460, 301 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 465, 292, 469, 301 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 418, 266, 422, 275 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 535, 240, 540, 249 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 306, 227, 315, 236 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 309, 201, 313, 210 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 318, 201, 323, 210 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 411, 175, 415, 184 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 419, 175, 424, 184 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 246, 163, 288, 170 Flags: Print Annotation: Subtype: Link Rect: 48, 154, 96, 161 Flags: Print Annotation: Subtype: Link Rect: 223, 116, 288, 123 Flags: Print Annotation: Subtype: Link Rect: 48, 107, 116, 114 Flags: Print Annotation: Subtype: Link Rect: 48, 71, 142, 78 Flags: Print Page: Sequence: 2 Annotations: Annotation: Subtype: Link Rect: 209, 721, 219, 730 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 224, 721, 233, 730 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 209, 695, 213, 704 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 218, 695, 228, 704 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 229, 669, 238, 678 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 52, 552, 61, 561 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 65, 552, 74, 561 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 70, 474, 80, 483 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 92, 422, 101, 431 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 258, 190, 267, 200 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 273, 190, 282, 200 Flags: Print Destination: 79 Page: Sequence: 3 Annotations: Annotation: Subtype: Link Rect: 230, 186, 288, 195 Flags: Print Annotation: Subtype: Link Rect: 48, 173, 77, 182 Flags: Print Annotation: Subtype: Link Rect: 87, 173, 96, 182 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 443, 478, 539, 487 Flags: Print Annotation: Subtype: Link Rect: 398, 425, 426, 435 Flags: Print Destination: 34 Annotation: Subtype: Link Rect: 487, 320, 544, 330 Flags: Print Annotation: Subtype: Link Rect: 306, 307, 336, 316 Flags: Print Annotation: Subtype: Link Rect: 409, 215, 418, 225 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 450, 163, 478, 172 Flags: Print Destination: 38 Page: Sequence: 4 Annotations: Annotation: Subtype: Link Rect: 108, 253, 146, 263 Flags: Print Destination: 45 Annotation: Subtype: Link Rect: 165, 253, 254, 263 Flags: Print Annotation: Subtype: Link Rect: 105, 71, 141, 81 Flags: Print Destination: 45 Annotation: Subtype: Link Rect: 160, 71, 246, 81 Flags: Print Annotation: Subtype: Link Rect: 364, 591, 396, 600 Flags: Print Destination: 56 Annotation: Subtype: Link Rect: 416, 591, 505, 600 Flags: Print Annotation: Subtype: Link Rect: 419, 383, 460, 392 Flags: Print Destination: 65 Annotation: Subtype: Link Rect: 487, 383, 544, 392 Flags: Print Annotation: Subtype: Link Rect: 306, 370, 334, 379 Flags: Print Annotation: Subtype: Link Rect: 309, 214, 346, 223 Flags: Print Destination: 65 Annotation: Subtype: Link Rect: 366, 214, 455, 223 Flags: Print Annotation: Subtype: Link Rect: 437, 136, 446, 145 Flags: Print Destination: 79 Page: Sequence: 5 Page: Sequence: 6 Annotations: Annotation: Subtype: Link Rect: 52, 110, 61, 119 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 128, 71, 137, 80 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 502, 136, 511, 145 Flags: Print Destination: 79 Page: Sequence: 7 Annotations: Annotation: Subtype: Link Rect: 205, 123, 215, 132 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 177, 97, 187, 106 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 471, 123, 480, 132 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 530, 123, 539, 132 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 354, 110, 363, 119 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 428, 110, 437, 119 Flags: Print Destination: 79 Page: Sequence: 8 Annotations: Annotation: Subtype: Link Rect: 52, 669, 61, 678 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 273, 578, 282, 587 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 140, 526, 149, 535 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 178, 474, 183, 483 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 273, 344, 282, 353 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 84, 305, 93, 314 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 259, 214, 269, 223 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 273, 214, 282, 223 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 309, 695, 313, 704 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 320, 695, 330, 704 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 409, 656, 418, 665 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 364, 422, 369, 431 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 455, 357, 459, 366 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 463, 357, 471, 366 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 474, 318, 483, 327 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 516, 292, 525, 301 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 530, 292, 539, 301 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 530, 266, 539, 275 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 443, 240, 452, 249 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 481, 188, 489, 197 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 309, 71, 318, 80 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 326, 71, 335, 80 Flags: Print Destination: 83 Annotation: Subtype: Link Rect: 343, 71, 352, 80 Flags: Print Destination: 83 Page: Sequence: 9 Annotations: Annotation: Subtype: Link Rect: 99, 669, 103, 678 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 87, 656, 92, 665 Flags: Print Destination: 79 Annotation: Subtype: Link Rect: 56, 437, 136, 445 Flags: Print Annotation: Subtype: Link Rect: 269, 181, 288, 189 Flags: Print Annotation: Subtype: Link Rect: 48, 171, 142, 179 Flags: Print Annotation: Subtype: Link Rect: 306, 611, 312, 618 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 584, 312, 591 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 557, 312, 564 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 530, 312, 537 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 512, 312, 519 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 485, 312, 492 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 458, 312, 465 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 431, 312, 438 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 404, 312, 411 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 386, 312, 393 Flags: Print Destination: 234 Annotation: Subtype: Link Rect: 306, 359, 312, 366 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 341, 312, 348 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 323, 312, 330 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 296, 312, 303 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 260, 312, 267 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 206, 312, 213 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 161, 312, 168 Flags: Print Destination: 56 Annotation: Subtype: Link Rect: 306, 116, 312, 123 Flags: Print Destination: 56 Annotation: Subtype: Link Rect: 306, 89, 312, 96 Flags: Print Destination: 65 Page: Sequence: 10 Annotations: Annotation: Subtype: Link Rect: 48, 736, 55, 743 Flags: Print Destination: 65 Annotation: Subtype: Link Rect: 48, 709, 55, 716 Flags: Print Destination: 65 Annotation: Subtype: Link Rect: 48, 673, 55, 680 Flags: Print Destination: 65 Annotation: Subtype: Link Rect: 48, 637, 55, 644 Flags: Print Destination: 76 Annotation: Subtype: Link Rect: 306, 736, 312, 743 Flags: Print Destination: 76 Annotation: Subtype: Link Rect: 306, 718, 312, 725 Flags: Print Destination: 76 Annotation: Subtype: Link Rect: 306, 691, 312, 698 Flags: Print Destination: 76 Annotation: Subtype: Link Rect: 306, 655, 312, 662 Flags: Print Destination: 76 Annotation: Subtype: Link Rect: 306, 637, 312, 644 Flags: Print Destination: 76 Checksum: aa57121b Type: CRC32 Checksum: 5ebb67c9fd07395c97e41e2ddb60c30c Type: MD5 Checksum: 23ab71403de5863dbc33844eaeb24f009055418c Type: SHA-1 Checksum: 8c4960daa8a86f4257edc61c097d8a95182edd949b1b82dcf3fd819b72fb7fcb Type: SHA-256